Skip to main content
Featured products
OSYPKA PACE 101H® is a single-chamber external pacemaker ideal for temporary cardiac pacing in…
Wide range of anterograde and retrograde cardioplegia cannulas, cardiac suctions, and perfusion…
The ICONCore® is a portable, non-invasive cardiometer that enables continuous measurement of…
CoraSim® is a heart simulator designed for training and education in cardiac electrophysiology…
The OSYPKA PACE 300® is a three-chamber external pacemaker designed for temporary biventricular…
Balloon dilatation catheter for percutaneous transluminal valvuloplasty, ideal for TAVI…

    Spain maintains its global leadership in organ transplantation in 2025 thanks to medical innovation and advanced technologies

    Spain has once again reaffirmed its position as a global leader in organ transplantation, surpassing 6,300 procedures carried out in 2025, with a rate of 51.9 donors per million population. These figures consolidate the Spanish healthcare model and its firm commitment to organ donation and transplantation.
    >According to data presented by the National Transplant Organisation (ONT), 6,335 organ transplants were performed in 2025, keeping Spain at the top internationally for the second consecutive year in a medical activity of high complexity and enormous social impact.

    Technological innovation and advanced organ preservation

    One of the key factors behind this leadership is the adoption and widespread use of organ preservation procedures using extracorporeal circulation devices (ECMO). This advanced technology makes it possible to maintain the viability of organs suitable for transplantation. Even in highly complex clinical situations, leading to improved clinical outcomes and expanding therapeutic options for patients.

    Cardiac transplantation after circulatory death: a clinical milestone

    Due to its particular technical complexity, only nine countries worldwide successfully carry out this type of procedure. In Spain, cardiac transplantation after circulatory death, performed following the donor’s cardiorespiratory arrest, now accounts for 35% of all heart transplants. This figure reflects the high level of clinical and technological development of the Spanish transplant system.

    A strong and coordinated healthcare system

    In addition to heart transplantation, kidney, liver, lung and other specialised transplants have contributed to maintaining exceptional donation and transplantation figures. All of this is the result of a robust, well-coordinated healthcare system with a long-standing record of excellence in this field.

    Organisational model, solidarity and innovation

    The combination of an efficient organisational model, a strong culture of solidarity and technological advances such as ECMO systems has enabled Spain not only to maintain. Also to continue strengthening its global leadership in organ transplantation, setting the benchmark for advanced medicine and healthcare innovation.